{"transactions":[{"id":1678361,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":95157,"kind":"person","name":"Mehra Raj","position":1,"cik":"0001757892","reported_name":"Mehra Raj","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-17T21:47:31.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":70383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on January 12, 2025, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":70383,"derivative":{"exercise_price":1.41,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":70383},"source":{"system":"sec-edgar","filing":"0001104659-24-004597","document":"tm242318-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000110465924004597/tm242318-6_4seq1.xml","form_type":"4"}},{"id":1725910,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":95157,"kind":"person","name":"Mehra Raj","position":1,"cik":"0001757892","reported_name":"Mehra Raj","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock Warrant (right to buy)","published_at":"2023-12-01T16:16:02.000Z","date":"2023-12-01","kind":"purchase","planned":false,"acquired":true,"shares":75757,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock was purchased together with an accompanying warrant to purchase one share of common stock in an underwritten public offering at a combined offering price of $1.32 per share of common stock and accompanying warrant."}],"balance_after":75757,"derivative":{"exercise_price":1.32,"exercise_date":"2023-12-01","expiration_date":"2028-12-01","underlying":"Common Stock","underlying_shares":75757},"source":{"system":"sec-edgar","filing":"0001104659-23-122840","document":"tm2331921-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000110465923122840/tm2331921-1_4seq1.xml","form_type":"4"}},{"id":1725909,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":95157,"kind":"person","name":"Mehra Raj","position":1,"cik":"0001757892","reported_name":"Mehra Raj","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-12-01T16:16:02.000Z","date":"2023-12-01","kind":"purchase","planned":false,"acquired":true,"shares":75757,"price":1.32,"value":99999.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock was purchased together with an accompanying warrant to purchase one share of common stock in an underwritten public offering at a combined offering price of $1.32 per share of common stock and accompanying warrant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective on November 28, 2023, the Issuer conducted a reverse stock split at a ratio of 1-for-30 (the \"Reverse Split\"). The number of shares reported herein reflects the number of shares after the Reverse Split."}],"balance_after":185142,"source":{"system":"sec-edgar","filing":"0001104659-23-122840","document":"tm2331921-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000110465923122840/tm2331921-1_4seq1.xml","form_type":"4"}},{"id":1934393,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":95157,"kind":"person","name":"Mehra Raj","position":1,"cik":"0001757892","reported_name":"Mehra Raj","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-31T17:10:38.000Z","date":"2023-03-30","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person voluntarily elected to be paid 36% of his 2022 annual cash bonus in the form of an option to purchase shares of common stock of the Issuer."}],"balance_after":200000,"derivative":{"exercise_price":0.69,"exercise_date":"2023-03-30","expiration_date":"2033-03-30","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-23-040292","document":"tm2311208-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000110465923040292/tm2311208-2_4seq1.xml","form_type":"4"}},{"id":1934392,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":95157,"kind":"person","name":"Mehra Raj","position":1,"cik":"0001757892","reported_name":"Mehra Raj","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-31T17:10:38.000Z","date":"2023-03-30","kind":"grant","planned":false,"acquired":true,"shares":1682300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on March 30, 2024, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":1682300,"derivative":{"exercise_price":0.69,"expiration_date":"2033-03-30","underlying":"Common Stock","underlying_shares":1682300},"source":{"system":"sec-edgar","filing":"0001104659-23-040292","document":"tm2311208-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000110465923040292/tm2311208-2_4seq1.xml","form_type":"4"}},{"id":2313421,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":95157,"kind":"person","name":"Mehra Raj","position":1,"cik":"0001757892","reported_name":"Mehra Raj","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-31T16:34:22.000Z","date":"2022-03-31","kind":"purchase","acquired":true,"shares":66667,"price":0.8526,"value":56840.2842,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were acquired in multiple open market transactions at prices ranging from $0.8454 per share to $0.8600 per share, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price."}],"balance_after":3281546,"source":{"system":"sec-edgar","filing":"0001136261-22-000159","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000113626122000159/ownership.xml","form_type":"4"}},{"id":2339174,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":95157,"kind":"person","name":"Mehra Raj","position":1,"cik":"0001757892","reported_name":"Mehra Raj","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B common stock","published_at":"2022-03-10T17:32:02.000Z","date":"2022-01-06","kind":"other","acquired":true,"shares":953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"},{"field":"kind","element":"transactionCoding","label":"F2","text":"As contemplated in connection with the initial public offering of the Issuer, 953 shares of Class B common stock of the Issuer were forfeited for no consideration and cancelled because the underwriters of the Issuer's initial public offering did not exercise their over-allotment option in full, as described in the Issuer's Registration Statement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"}],"balance_after":8631,"derivative":{"underlying":"Class A common stock","underlying_shares":953},"source":{"system":"sec-edgar","filing":"0001213900-22-011645","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1757892/000121390022011645/ownership.xml","form_type":"4"}},{"id":2438199,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":95157,"kind":"person","name":"Mehra Raj","position":1,"cik":"0001757892","reported_name":"Mehra Raj","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-11T16:29:17.000Z","date":"2022-01-10","kind":"grant","acquired":true,"shares":1300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on January 10, 2023, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":1300000,"derivative":{"exercise_price":1.46,"expiration_date":"2032-01-10","underlying":"Common Stock","underlying_shares":1300000},"source":{"system":"sec-edgar","filing":"0001136261-22-000042","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000113626122000042/ownership.xml","form_type":"4"}},{"id":2783827,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":95157,"kind":"person","name":"Mehra Raj","position":1,"cik":"0001757892","reported_name":"Mehra Raj","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-17T16:41:24.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":1150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on March 15, 2022, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":1150000,"derivative":{"exercise_price":4.31,"expiration_date":"2031-03-15","underlying":"Common Stock","underlying_shares":1150000},"source":{"system":"sec-edgar","filing":"0001136261-21-000041","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000113626121000041/primary_doc.xml","form_type":"4"}},{"id":3112332,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":95157,"kind":"person","name":"Mehra Raj","position":1,"cik":"0001757892","reported_name":"Mehra Raj","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-06-12T16:15:17.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":2282262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on June 11, 2021, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":2282262,"derivative":{"exercise_price":1.08,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":2282262},"source":{"system":"sec-edgar","filing":"0001136261-20-000138","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000113626120000138/primary_doc.xml","form_type":"4"}},{"id":3271677,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":95157,"kind":"person","name":"Mehra Raj","position":1,"cik":"0001757892","reported_name":"Mehra Raj","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-14T16:36:58.000Z","date":"2020-02-13","kind":"purchase","acquired":true,"shares":133333,"price":0.75,"value":99999.75,"ownership":{"direct":true},"balance_after":3214879,"source":{"system":"sec-edgar","filing":"0001136261-20-000053","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000113626120000053/primary_doc.xml","form_type":"4"}},{"id":3316793,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":95157,"kind":"person","name":"Mehra Raj","position":1,"cik":"0001757892","reported_name":"Mehra Raj","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-07T16:30:14.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":731000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on January 6, 2021, and 1/4th of the shares subject to the option shall vest annually thereafter."}],"balance_after":731000,"derivative":{"exercise_price":1.42,"expiration_date":"2030-01-06","underlying":"Common Stock","underlying_shares":731000},"source":{"system":"sec-edgar","filing":"0001136261-20-000008","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000113626120000008/primary_doc.xml","form_type":"4"}},{"id":3685754,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":95157,"kind":"person","name":"Mehra Raj","position":1,"cik":"0001757892","reported_name":"Mehra Raj","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-01-28T16:31:10.000Z","date":"2019-01-24","kind":"grant","acquired":true,"shares":3081546,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of common stock of the corporation formerly known as Seelos Therapeutics, Inc. (\"Seelos\") were converted into shares of common stock of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of July 30, 2018, by and among the Issuer, Arch Merger Sub, Inc. and Seelos, as amended (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, each share of Seelos common stock was exchanged for 0.7704 shares of the Issuer's common stock. Immediately following the merger, the Issuer changed its name to Seelos Therapeutics, Inc. All share numbers reflect the one-for-thirty reverse stock split effected by the Issuer immediately prior to the completion of the merger."}],"balance_after":3081546,"source":{"system":"sec-edgar","filing":"0001136261-19-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000113626119000011/primary_doc.xml","form_type":"4"}}]}